DISC-3405

Disc Medicine, Inc · Phase 2 active Small molecule

At a glance

Generic name	DISC-3405
Also known as	9MW3011
Sponsor	Disc Medicine, Inc
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV) (PHASE2)
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD) (PHASE1)
A Study of DISC-3405 in Healthy Volunteers (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

DISC-3405 CI brief — competitive landscape report
DISC-3405 updates RSS · CI watch RSS
Disc Medicine, Inc portfolio CI